In the study of the correlation of gene expression, we found gastric cancer patients with a relatively high expression of DR5 also had a higher expression of m6A‐related genes and immune checkpoint genes, which indicated that DR5 might be involved in the post‐transcriptional modification and immune resistance. Here, TNFRSF10B is linked to gastric cancer.